OPERATOR-LED AI PRODUCT STRATEGY

Your AI product works.
Your commercial model doesn't.
That gap is the whole engagement.

We're operators, not consultants. We've priced, shipped, and cleared AI products at GE Healthcare, NavVis, ADP, and Nokia — and we sit with founders, CPOs, and PE operating partners through the 90 days where the commercial model either closes the gap or loses the year.

Book a 25-min intro → Diagnose your commercial model → 25 minutes · direct with a partner · no pitch
$40M+
P&L run by partners
30×
Willingness-to-pay revalidated · Case 07
90d
Zero commercial strategy → funded launch
PARTNERS HAVE OPERATED AT
GE Healthcare
GE Healthcare
EY
EY
eBay
eBay
NavVis
NavVis
Klarna
Klarna
HERE WeGo
HERE
WPP
WPP
Apple
Apple
Oracle
Oracle
Citi
Citi
Dassault Systèmes
Dassault Systèmes
ADP
ADP
GE Healthcare
GE Healthcare
EY
EY
eBay
eBay
NavVis
NavVis
Klarna
Klarna
HERE WeGo
HERE
WPP
WPP
Apple
Apple
Oracle
Oracle
Citi
Citi
Dassault Systèmes
Dassault Systèmes
ADP
ADP

OUR EDGE

CPO + CTO
in one room.

Most consulting engagements split the product brief from the architecture brief. The product consultant writes one thing. The tech consultant writes another. Your engineering team spends weeks deciding who's right.

We work the problem from both sides in the same session — a CPO and CTO bench with 114 combined years shipping at ADP, Citi, Oracle, GE Healthcare, EY, eBay, SunGard, Dassault Systèmes.

What ships matches what was designed. No translation layer. No handoff. One room. One decision.

114yr
Combined CPO + CTO tenure on the team bench
1session
Strategy and architecture resolved together — not two engagements

FIVE QUESTIONS · TWELVE MINUTES

Where is your commercial model leaking?

A 12-minute diagnostic that asks the questions your board will ask before they ask them. The output isn't a score. It's a decision memo — three priorities for the quarter, each matched to the move that fixes it.

Run the diagnostic →
YOU'LL ANSWER QUESTIONS LIKE
  • Is your pricing floor still anchored to pre-2024 compute assumptions?
  • Can your CFO defend margin through three compute-cost scenarios?
  • Does your sales team know which 30% of denials are worth fighting?
  • Is your InfoSec package cleared once, or vendor-by-vendor?
  • Where does your AI workflow leave an audit trail — and where doesn't it?
Output: a 2-page decision memo · no score · no lead-nurture
CASE STUDY 07 · OUTCOME
30×

Willingness-to-pay validated at roughly thirty times the company's initial pricing assumptions — on a $90M ARR five-year path.

HEALTHCARE AI · CLINICAL APPEALS · 90 DAYS

AI was priced as software. Buyers were pricing it as recovered revenue.

A market-dominant clinical-guidelines company had a working AI appeals product and no commercial model. In under 90 days we rebuilt the pricing frame around the metric that moves CFOs — recovered revenue, not software features — and stood up the five-year financial model the board could defend.

Discuss this engagement →

WHAT WE BELIEVE · WHY CLIENTS HIRE US

Four things
most advisors won't say out loud.

01

Operators triage. Consultants scope.

We'd rather tell you in 25 minutes that your problem isn't ours than build a six-week discovery phase that pretends it is.

02

The bottleneck isn't the model. It's the organization around it.

Better AI doesn't fix a company that can't absorb it. The firms pulling ahead are treating governance, pricing, and learning as one system.

03

If the CFO can't defend it, the board won't approve it.

Every pricing model we build survives three compute-cost scenarios, and every engagement ships a finance narrative the CFO can walk into a board meeting with.

04

A decision memo beats a 200-slide deck.

Every engagement ends in a two-page document: what to change, what it's worth, what it costs to execute. Frameworks you admire vs. systems your company runs on Monday.

Twenty-five minutes.
One partner.
The problem you actually have.

We'd rather spend twenty-five minutes finding out whether this fits than scope an engagement that doesn't. Most calls end with a clear next step — sometimes with us, sometimes with someone we trust.